High-Dose Oral Vancomycin for Treatment of Clostridioides difficile Is Associated With High Risk of Subsequent Cultures With Gram-Negative Organisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Oral Vancomycin for Treatment of Clostridioides difficile Is Associated With High Risk of Subsequent Cultures With Gram-Negative Organisms

Published:2021-06-25 Issue:6 Volume:29 Page:e361-e365
ISSN:1536-9943
Container-title:Infectious Diseases in Clinical Practice
language:en
Short-container-title:Infect Dis Clin Pract

Author:

Bader Mazen S.,Someili Ali,Alosali Abdulmajeed,Hadzic Amir,Irfan Neal,Leto Daniela,Mertz Dominik,Brooks Annie A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical)

Reference24 articles.

1. Trends in U.S. burden of Clostridioides difficile infection and outcomes;N Engl J Med,2020

2. Diagnosis and treatment of Clostridium difficile in adults: a systematic review;JAMA,2015

3. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA);Clin Infect Dis,2018

4. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection;Clin Infect Dis,2012

5. Effect of fidaxomicin versus vancomycin on susceptibility to intestinal colonization with vancomycin-resistant enterococci and Klebsiella pneumoniae in mice;Antimicrob Agents Chemother,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP